Search

Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India

Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.

Boehringer Ingelheim India recognized as Top Employer 2024

Global Code of Conduct

Our Code of Conduct demonstrates for each and every one that integrity is “part of our DNA”. Click here to learn more about our Code of Conduct.

Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug

Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug.

Looking behind the scenes of Afrika Kommt!

Since inception in 2008, Afrika Kommt! has upskilled over 156 young professionals from Sub-Saharan Africa. Learn more about this programme here.

1885-1948

In 1885, Albert Boehringer purchased a small tartar factory in the Rhine-Hessian village of Nieder-Ingelheim. Click here to learn more about our history.

Reggie the Red Blood Cell

Join Reggie, our curious red blood cell, on a journey exploring connections between the heart, kidneys and pancreas. Click here to read more!

Boehringer Ingelheim India’s stroke awareness campaign enters the GUINNESS WORLD RECORDS™

Boehringer Ingelheim India’s stroke awareness campaign enters the GUINNESS WORLD RECORDS™. Click here to read the press release and find out more.

1988-2015

Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here.

Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India

Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India. Click here to find out and learn more.

Boehringer Ingelheim and IIT Kanpur join hands for social impact

Boehringer Ingelheim India to support Lenek Technologies, a startup incubated at SIIC, IIT Kanpur to improve tuberculosis screening through its innovative handheld X-ray device.

COVID-19 Joining forces against COVID-19

While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.

Purchasing

Find out information about Boehringer Ingelheim's purchasing and supplier relationships here, as well as links to useful resources for suppliers too.

COVID-19 Boehringer Ingelheim Singapore charity donations

Find out how Boehringer Ingelheim Singapore is offering support for healthcare workers and vulnerable communities. Click here to learn more.

More Green

Our MORE GREEN pillar encompasses environmental initiatives that consider many different aspects. Click here to learn more about our MORE GREEN pillar.

1948-1988

Following the death of Albert Boehringer (1861-1939), his two sons and his son-in-law Julius Liebrecht took over this family company. Learn more.

Solidarity with Ukraine

Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term. Click here to learn more.

COVID-19 Learning from the pandemic

Online training options develop vets and other animal health professionals’ skills helping them overcome movement restrictions to thrive around the globe.

UK donates to vulnerable children and local emergency fund

Find out how colleagues in the UK are helping disadvantaged young people in isolation, and supporting charities in the community. Click here to learn more.

COVID-19 Global Access Commitment with Gates Foundation

Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing a communiqué with the Bill & Melinda Gates Foundation.

EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalization for heart-failure and cardiovascular death

EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalisation for heart-failure and cardiovascular death. Find out more here.

Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease

Jardiance® (empagliflozin) now approved in India

Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine

Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine. Click here to find out and learn more information.

preventive care cat veterinarian

What can we all, as cat owners or veterinarians, do to promote cat health? Click here to read about this subject and find out more information.

Priya Chandramohan

About Us

Human Health

Animal Health